Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alkermes Plc (ALKS)  
$24.71 0.66 (2.74%) as of 4:30 Mon 5/13


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 183,678,000
Market Cap: 4.54(B)
Last Volume: 775,760 Avg Vol: 773,615
52 Week Range: $23.37 - $33.63
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Delivery

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  581
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alkermes is a biopharmaceutical company. Co. has a portfolio of marketed products focused on central nervous system disorders such as addiction and schizophrenia and a pipeline of product candidates in the fields of neuroscience and oncology. Co.'s proprietary products include: ARISTADA, which is an extended-release intramuscular injectable suspension approved in the U.S. for the treatment of schizophrenia; ARISTADA INITIO, which is indicated for the initiation of ARISTADA when used for the treatment of schizophrenia in adults; and VIVITROL, which is for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 35,000
Total Buy Value $0 $0 $0 $815,735
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 15,666 15,666 48,238 146,962
Total Sell Value $454,291 $454,291 $1,411,373 $4,368,837
Total People Sold 3 3 3 5
Total Sell Transactions 3 3 6 9
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 1496
  Page 16 of 60  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hopkinson Craig C. EVP R&D, Chief Medical Officer   •       •      –    2021-02-20 4 D $19.58 $59,993 D/D (3,064) 24,067     -
   Hopkinson Craig C. EVP R&D, Chief Medical Officer   •       •      –    2021-02-20 4 OE $0.00 $0 D/D 10,095 27,131     -
   Jackson Blair Curtis EVP, Chief Operating Officer   •       •      –    2021-02-20 4 D $19.58 $26,903 D/D (1,374) 64,766     -
   Jackson Blair Curtis EVP, Chief Operating Officer   •       •      –    2021-02-20 4 OE $0.00 $0 D/D 4,589 66,140     -
   Gaffin David Joseph SVP, CLO, Alkermes, Inc.   •       •      –    2021-02-20 4 D $19.58 $40,354 D/D (2,061) 69,744     -
   Gaffin David Joseph SVP, CLO, Alkermes, Inc.   •       •      –    2021-02-20 4 OE $0.00 $0 D/D 7,036 71,805     -
   Nichols Christian Todd SVP, Chief Commercial Officer   •       •      –    2021-02-20 4 D $19.58 $25,297 D/D (1,292) 5,003     -
   Nichols Christian Todd SVP, Chief Commercial Officer   •       •      –    2021-02-20 4 OE $0.00 $0 D/D 3,824 6,295     -
   Brown Iain Michael SVP, Chief Financial Officer   •       •      –    2021-02-20 4 D $19.58 $26,981 D/D (1,378) 44,974     -
   Brown Iain Michael SVP, Chief Financial Officer   •       •      –    2021-02-20 4 OE $0.00 $0 D/D 4,589 46,352     -
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2021-02-20 4 OE $0.00 $0 D/D 11,178 219,368     -
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2021-02-20 4 D $19.58 $46,209 D/D (2,360) 213,543     -
   Gaffin David Joseph SVP, CLO, Alkermes, Inc.   •       •      –    2021-02-17 4 D $19.97 $17,334 D/D (868) 64,769     -
   Gaffin David Joseph SVP, CLO, Alkermes, Inc.   •       •      –    2021-02-17 4 OE $0.00 $0 D/D 2,500 65,637     -
   Jackson Blair Curtis EVP, Chief Operating Officer   •       •      –    2021-02-17 4 D $19.97 $15,597 D/D (781) 61,551     -
   Jackson Blair Curtis EVP, Chief Operating Officer   •       •      –    2021-02-17 4 OE $0.00 $0 D/D 2,250 62,332     -
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2021-02-17 4 D $19.97 $29,795 D/D (1,492) 210,550     -
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2021-02-17 4 OE $0.00 $0 D/D 3,000 212,042     -
   Brown Iain Michael SVP, Chief Financial Officer   •       •      –    2021-02-17 4 D $19.97 $17,334 D/D (868) 41,763     -
   Brown Iain Michael SVP, Chief Financial Officer   •       •      –    2021-02-17 4 OE $0.00 $0 D/D 2,500 42,631     -
   Pops Richard F Director and CEO, Alkermes plc   •       •      –    2021-02-17 4 D $19.97 $77,264 D/D (3,869) 774,026     -
   Pops Richard F Director and CEO, Alkermes plc   •       •      –    2021-02-17 4 OE $0.00 $0 D/D 8,750 777,895     -
   Gaffin David Joseph SVP, CLO, Alkermes, Inc.   •       •      –    2021-02-16 4 D $19.79 $23,194 D/D (1,172) 63,137     -
   Gaffin David Joseph SVP, CLO, Alkermes, Inc.   •       •      –    2021-02-16 4 OE $0.00 $0 D/D 3,375 64,309     -
   Jackson Blair Curtis EVP, Chief Operating Officer   •       •      –    2021-02-16 4 D $19.79 $16,327 D/D (825) 60,082     -
  1496 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 16 of 60
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us